| Main Subject |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Presentation > Transitions: Building Bridges to Your Points |
|
Main Subject - Transitions: Building Bridges to Your Points
Presenters often tell me that they fear losing their train of thought. When listening to their talks According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product I realized that for many people, the problem is not forgetting the words or main points. Speakers fr ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in eeze because they can’t get from point A to point B. They know the next point but they struggle with lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. he transition.
And without transitions you will sound choppy and inexperienced. So how do you creat here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe e that smooth flow? First consider your points.
Let’s say your agenda items are • background histor d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro y • current situation • future trends You don’t want to simply say “Background history.” Y ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc u need a lead in.
Your segue can be as basic as “Let’s begin with some background history…” Now choo easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi se another transition such as “Next we’ll discuss our current situation…”
A transition can be phra nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically sed as a statement or question. “So what do we project for the future of the industry?…..”
In sales and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ resentations it’s very effective to verbalize what the customer is thinking. “You may be wondering h ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi ow much does it cost” “At this point you may be concerned with safety.” “So what is our tra ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ck record?” Transitions are the thread that weaves all the ideas together in a cohesive fashion. The dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod also help the audience to listen and comprehend the message. Transitions are road signs that signal cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin you are making a new point.
Here are a few transitions to bridge to your speaking points: “That br tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ings me to me next point which is…” “Now that we’ve discussed advertising, let’s take a look at dire t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel t mail…” “So far we’ve covered compensation and benefits, the next agenda item is training..” “In a ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ddition to cost containment, there is another area I’d like to discuss…” “Now let’s consider..” “To y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products begin with let’s take a look at…” “The next important factor is…” “I’d like to view the issue from . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de three aspects…” “Finally, let’s consider…” Remember to use transitions in all your presentations. Y elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip ou will have more attentive listeners, better retention and they’ll think you’re a real smooth talker tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:How to Share Important Documents in a Spam-Free Environment Be Prepared for the Unexpected
|